Optipharm.CO.,LTD (KOSDAQ:153710)

Optipharm.CO.,LTD Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 7, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	73,790	74,817	68,142	103,130	102,836	137,287
Market Cap Growth	-4.01%	9.79%	-33.93%	0.29%	-25.09%	-37.60%
Enterprise Value	74,462	74,646	64,237	96,968	93,065	120,665
Last Close Price	5030.00	5100.00	4645.00	7030.00	7010.00	9410.00
PS Ratio	3.30	3.35	3.47	5.94	6.42	9.63
PB Ratio	2.91	2.95	2.49	4.10	3.55	4.43
P/TBV Ratio	2.94	2.98	2.52	4.15	3.58	4.47
EV/Sales Ratio	3.33	3.34	3.27	5.58	5.81	8.46
Debt / Equity Ratio	0.42	0.42	0.40	0.40	0.27	0.19
Net Debt / Equity Ratio	0.03	0.03	-0.12	-0.22	-0.31	-0.52
Net Debt / EBITDA Ratio	-0.91	-0.91	3.85	4.68	8.33	4.70
Net Debt / FCF Ratio	-0.16	-0.16	1.42	1.65	1.28	5.98
Asset Turnover	0.53	0.53	0.48	0.43	0.39	0.35
Inventory Turnover	10.82	10.82	11.20	10.90	11.41	11.87
Quick Ratio	0.93	0.93	1.23	1.49	2.02	2.97
Current Ratio	1.21	1.21	1.47	1.77	2.33	3.30
Return on Equity (ROE)	-9.48%	-9.48%	-8.98%	-9.00%	-6.82%	-9.52%
Return on Assets (ROA)	-3.59%	-3.59%	-3.71%	-4.09%	-3.32%	-6.83%
Return on Capital Employed (ROCE)	-8.60%	-8.60%	-8.00%	-9.50%	-6.90%	-13.50%
Earnings Yield	-3.39%	-3.34%	-3.46%	-2.36%	-1.99%	-2.24%
FCF Yield	-5.50%	-5.43%	-3.34%	-3.29%	-6.78%	-1.96%
Buyback Yield / Dilution	-0.44%	-0.44%	0.22%	-0.45%	-0.54%	-0.66%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.